Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.

IC

ICICI Prudential BHARAT 22 FOF - Cumulative Option

ICICI Prudential Mutual Fund · Other · FoF Domestic

₹32.84

+0.13 (+0.41%)

AUM: —

NAV updated 5 days ago

Risk

Very High

Sharpe Ratio

-0.35

Std Dev (1Y)

13.81%

Historical Returns (CAGR)

Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.

1m

-2.63%

3m

-7.17%

6m

-5.91%

1y

+1.37%

3y

+14.13%

5y

+20.46%

10y

—

since inception

+15.74%

TopFund's Take on ICICI Prudential BHARAT 22 FOF - Cumulative Option

ICICI Prudential BHARAT 22 FOF - Cumulative Option is a FoF Domestic fund from ICICI Prudential Mutual Fund.

Cost: Expense ratio data for this fund isn't available yet.

Risk-adjusted performance: Over the trailing 1-year period, the fund shows a negative Sharpe ratio of -0.35 — over the past year, returns haven't kept pace with the volatility involved, even before accounting for the risk-free rate. Separately, annualised volatility of 13.81% is fairly typical for FoF Domestic funds.

Who should invest: This fund is best suited to investors whose goals and risk appetite align with a Other fund. Given the Very High risk rating, this fund is not suited to short-term goals or investors who may need to exit within 2-3 years.

This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.

Sector Allocation

Sector allocation not available yet.

Asset Allocation

Asset allocation not available yet.

Frequently Asked Questions about ICICI Prudential BHARAT 22 FOF - Cumulative Option

* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

No comments yet — start the discussion.